CIK 0001704292 · Large accelerated filer
Zai Lab Ltd
Sign in to watch- Ticker
- ZLAB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 862161632588
- Business address
- 899 HALEI ROAD, BUILDING B, PUDONG, SHANGHAI, China
- Former names
- Zai Lab Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,020
- in 1 filing, $7K under 10b5-1 plans
Net −$7,020. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-12 | Chen Yajing Chief Financial Officer | Grant or award · Stock Options (Right to Buy) | +52,418 | 52,418 | ||
| 2025-03-12 | Chen Yajing Chief Financial Officer | Grant or award · Restricted Share Units | +17,035 | 17,035 | ||
| 2025-03-10 | Du Ying Chairperson & CEO | Grant or award · Stock Options (Right to Buy) | +252,585 | 252,585 | ||
| 2025-03-10 | Du Ying Chairperson & CEO | Grant or award · Restricted Share Units | +10,620 | 10,620 | ||
| 2025-03-05 | GAYNOR RICHARD Director | Sale 10b5-1 | −2,500 | $35.07 | $88K | 44,068 |
| 2025-03-05 | Du Ying Chairperson & CEO | Option exercise 10b5-1 | +46,389 | $0.60 | $28K | 540,506 |
| 2025-03-05 | Du Ying Chairperson & CEO | Sale 10b5-1 | −21,093 | $35.20 | $742K | 519,413 |
| 2025-03-05 | Du Ying Chairperson & CEO | Sale 10b5-1 | −25,296 | $35.84 | $907K | 494,117 |
| 2025-03-05 | Du Ying Chairperson & CEO | Option exercise · Stock Options (Right to Buy) 10b5-1 | −46,389 | 392,776 | ||
| 2025-03-04 | Du Ying Chairperson & CEO | Option exercise 10b5-1 | +50,000 | $0.60 | $30K | 544,117 |
| 2025-03-04 | Du Ying Chairperson & CEO | Sale 10b5-1 | −6,665 | $32.69 | $218K | 537,452 |
| 2025-03-04 | Du Ying Chairperson & CEO | Sale 10b5-1 | −37,752 | $33.55 | $1.3M | 499,700 |
| 2025-03-04 | Du Ying Chairperson & CEO | Sale 10b5-1 | −5,583 | $33.99 | $190K | 494,117 |
| 2025-03-04 | Du Ying Chairperson & CEO | Option exercise · Stock Options (Right to Buy) 10b5-1 | −50,000 | 439,165 | ||
| 2025-02-28 | Edmondson Frazor Titus III Chief Legal Officer | Sale 10b5-1 | −14,544 | $32.98 | $480K | 14,328 |
Page 15 of 15 · 295 trades